TEVA — Teva Pharmaceutical Industries Ltd
In 2026 Q2, 8 of the 140 tracked hedge funds reported a position in Teva Pharmaceutical Industries Ltd (TEVA), worth $947.36M combined. Over the quarter 2 opened or added, 6 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Lingotto | $684.58M | 14.70% | -27.2% |
| Polar Capital | $176.61M | 0.50% | +0.7% |
| VanEck | $45.94M | 0.03% | -18.5% |
| Duquesne | $21.18M | 0.49% | -73.7% |
| Ardsley | $15.75M | 1.70% | -16.2% |
| IMC | $1.24M | 0.01% | -59.2% |
| Steadtrust | $1.23M | 0.62% | +0.6% |
| Emerald | $831.69K | 0.02% | -28.4% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.